We represent the innovative pharmaceutical industry globally, with a focus on three priorities: innovation, equitable access, and ethics. #AlwaysInnovating
Geneva
- Tweets 16,229
- Following 1,218
- Followers 9,150
- Likes 4,482
Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security.
#AlwaysInnovating
7
1
2
2,614
From patient experiences to foundational scientific data, pharma R&D draws on many types of data. Used responsibly, data can accelerate new medicines and vaccines, and a data ecosystem that supports innovation helps patients benefit sooner.
ifpma.org/areas-of-work/fost…
69
With 4,700+ potential cancer medicines in development, partnerships in LMICs are key to making sure these innovations reach the people who need them. @DavidReddyIFPMA makes the case for investing in innovation in Cancer Control 2026 👇
cancercontrol.info/cc26-cont…
86
Influenza vaccination can generate up to USD 22 in societal benefits for every USD 1 invested. This #WorldFluDay, discover the value of every 1% increase in coverage 👇
ifpma.org/resources/the-valu…
101
Longer lives bring both opportunities and challenges. In @japantimes, @DavidReddyIFPMA and @JPMA’s @Go Takahashi explain how prevention can help older adults stay healthy and independent for longer 👇
japantimes.co.jp/commentary/…
1
93
A strong IP system helps turn scientific ideas into health breakthroughs. @DavidReddyIFPMA on what @WIPO’s #GlobalInnovationIndex highlights about innovation ecosystems 👇
ifpma.org/insights/from-pilo…
1
83
Vulnerability does not begin at 65. Discover how treating preventive care as an investment can help Europe turn longer lives into stronger economies and set a global example 👇
ifpma.org/insights/longer-he…
77
#NCDs are both a health and an economic challenge. IFPMA Executive Director, Global Health, Access, and Financing, Derrick Sim, makes the case for treating NCDs as an investment in healthier lives, stronger labor markets, and more resilient economies 👇
linkedin.com/pulse/case-trea…
1
1
83
IFPMA retweeted
Pharmaceutical innovation is not only an investment in health, but also in economic growth and resilience. @IFPMA Director General Dr. David Reddy examines why sustained investment in research and innovation is critical to healthier populations and stronger economies.
#HealthAPoliticalChoice #WHS2026 #HealthInnovation #GlobalHealth @WorldHealthSmt @IFPMA
globalgovernancemedia.org/ph…
2
1
76
On #WorldHeartDay, we’re reminded how prevention and innovation help people live healthier lives. CVRM conditions drive nearly half of NCD deaths, yet new diagnostics and treatments are transforming how we manage their interconnected progression.
🔗 ifpma.org/areas-of-work/adva…
1
1
1
166
Global health #security remains fragile. The #Ebola outbreak underscores the need for sustained investment in pharmaceutical innovation, stronger health systems, & policy and financing frameworks that make scientific progress possible.
Learn more 👇
ifpma.org/publications/stren…
113
Fostering innovation, strengthening health systems, and effective partnerships must be global priorities for today's global health architecture reform.
Read the op-ed by @DavidReddyIFPMA on @HealthPolicyWatch 👇
healthpolicy-watch.news/the-…
1
129
Adult #immunization is vital for healthy aging. By 2060, adults 55–64 will be 30% of the workforce. Each $1 invested returns up to 19×, while preventable diseases cost G20 economies $1T yearly.
🔗 Learn more:
ifpma.org/publications/adult…
114
🌍 As clinical research becomes increasingly global, greater convergence in clinical trial review processes can make all the difference by reducing delays and helping patients access innovative therapies faster, wherever they are.
📖 Download now:
ifpma.org/publications/consi…
95
1 in 3 people globally live with an NCD. 82% of premature NCD deaths happen in low- and middle-income countries.
140+ initiatives on #GlobalHealthProgress show how partnerships are closing that gap 👇
ifpma.info/4x1dSwt
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
105
As populations age and #NCDs rise, fewer workers support more with chronic illness.
Adults with #CVD are 10x more likely to suffer a heart attack after flu. NCDs cost the EU ~€437.7B/year in lost productivity.
🔗ifpma.org/publications/inves…
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
149
#Prevention is one of our most powerful tools against #NCDs.
Adult immunization is cost-effective, slows disease progression, cuts healthcare needs, and helps people stay independent in education or work.
🔗ifpma.info/3SVQaQw
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
119
Nearly half of NCD deaths link to preventable, interlinked cardiovascular, renal & metabolic (#CVRM) conditions.
Breakthroughs are transforming care for the 30-40% of people living with multimorbidities.
🔗 ifpma.info/4qIDm08
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
2
1
1
161
Medicines have transformed how the world fights #NCDs. The industry has launched 1,400+ new medicines in the past decade, with 9,600+ more in development.
🔗 Learn more:
ifpma.info/4l6cnHo
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
3
196
100 days since the #Ebola outbreak was declared in the DRC, IFPMA and @IAmBiotech underline the industry's track record on health emergencies and call for a #PABS system that strengthens industry engagement in pandemic response.
🔗Read the news release:
ifpma.org/news/100-day-miles…
1
176
Preventable diseases cost #G20 economies over USD 1 trillion annually in productivity among people aged 50–64.
Our new infographic with #GCOA explores vaccination as strategic economic infrastructure for productivity, healthy ageing, and preparedness.
bit.ly/3Tukq8S
1
174